Clinical Trial Detail

NCT ID NCT01099423
Title Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer
Recruitment Unknown status
Gender both
Phase Phase III
Variant Requirements No
Sponsors European Organisation for Research and Treatment of Cancer - EORTC
Indications

clear cell renal cell carcinoma

Therapies

Sunitinib

Age Groups: adult

No variant requirements are available.